HHS cutting red tape to speed clinical trials
Posted by Michael Jay on Thu, Sep 01, 2011
Written by Adam Chasse, Vice President, Corporate Development at RxTrials
Source:HHS cutting red tape to speed clinical trials
American Medical News
HHS’s proposal to require protocol approval by a single central IRB could trim study startup timelines, particularly for indications more likely to be studied in academic and hospital settings. If enacted, this will be one critical step in accelerating drug development. But as with all new policies, there will be benefits to some stakeholders and detriments to others – all of which may make for some interesting lobbying. more...